AMLX: amylyx.com Expected earnings per share growth for next year

Public company logo of Amylyx Pharmaceuticals (AMLX)

The consensus EPS growth forecast for next year reflects market expectations, with the latest parameter standing at 15.40. Stable raw material supplies amid global tensions are critical for therapy certification. The financial stability of Amylyx Pharmaceuticals (AMLX) is limited by its dependence on a single drug, which poses a risk of losing approval. Simultaneously, the company is battling the departure of key scientists in an effort to preserve its core R&D potential.

Amylyx Pharmaceuticals Inc (AMLX): Net earnings per share change forecast for next year from 07/04/2022 to 11/15/2026

Analytical breakdowns and data insights for company Amylyx Pharmaceuticals Inc (AMLX)

Fundamental company valuation:AMLX, amylyx.com
Finished products of Amylyx Pharmaceuticals, Inc.

Following the catastrophic recall of its key ALS drug and the subsequent erosion of brand trust, Amylyx Pharmaceuticals (AMLX) is currently undergoing a phase of deep strategic transformation. The trend in estimated net earnings per share growth for the coming year mathematically captures shifts in expert consensus forecasts, allowing investors to objectively assess the revision of yield expectations and adjust the cost of capital amid high-risk conditions.

Analysis of competing companies

Net earnings per share growth forecast for next year Biogen|Expected earnings per share growth for next year neurocrine.com (NBIX)|Net earnings per share growth forecast for next year Regencell Bioscience Holdings Limited (RGC)|AXSM (Axsome Therapeutics Inc) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year ACADIA Pharmaceuticals Inc. ACAD|Expected earnings per share trend next year XENE|Viking Therapeutics - Earnings growth forecast for next year|Expected earnings per share trend next year SUPN (supernus.com)|Catalyst Pharmaceuticals (CPRX) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Denali (DNLI)|Net earnings per share growth forecast for next year harmonybiosciences.com|BHVN (Biohaven Pharmaceutical) - Projected earnings per share increase next year|Net earnings per share growth forecast for next year Trevi Pharma (TRVI)|Consensus forecast of earnings per share growth for next year praxismedicines.com|Net earnings per share growth forecast for next year Anavex AVXL|Consensus forecast of earnings per share growth for next year CeriBell (CBLL)|PRTA - Net earnings per share growth forecast for next year|ALEC: Net earnings per share growth forecast for next year|Annexon (ANNX) - Net earnings per share growth forecast for next year|OMER: Projected earnings per share increase next year|NGNE (neurogene.com) - Earnings growth forecast for next year|Earnings growth forecast for next year AC Immune S.A.|Expected earnings per share growth for next year VYGR (Voyager Therapeutics, Inc.)|Projected earnings per share increase next year NMRA|Net earnings per share growth forecast for next year scilexholding.com SCLX|TVGN: Projected earnings per share growth rate for next year|alphacognition.com - Earnings growth forecast for next year|Cognition Therapeutics - Projected earnings per share increase next year|IKT: Earnings growth forecast for next year|Expected earnings per share growth for next year Cassava Sciences, Inc.|ASRT (assertiotx.com) - Earnings growth forecast for next year|Expected earnings per share growth for next year Coya Therapeutics (COYA)|Expected earnings per share growth for next year VTGN (Vistagen)|Consensus forecast of earnings per share growth for next year Ovid Therapeutics Inc|Earnings growth forecast for next year ABOS (Acumen Pharmaceuticals Inc.)|CRVO - Expected earnings per share growth for next year|Alterity Therapeutics Limited - Earnings growth forecast for next year|Expected net earnings per share growth next year Clene Inc|PEPG: Earnings growth forecast for next year|Expected earnings per share growth for next year jupiterneurosciences.com|RLMD (relmada.com) - Earnings growth forecast for next year|Earnings growth forecast for next year Annovis Bio Corporation|Earnings growth forecast for next year GRCE|AIFF: Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year Klotho Neurosciences KLTO|NRSN: Projected earnings per share growth rate for next year|RVPH: Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year MetaVia MTVA|neuraxis.com (NRXS) - Net earnings per share growth forecast for next year|Helius Medical Technologies Inc. - Expected earnings per share trend next year|PASG (Passage Bio, Inc.) - Earnings growth forecast for next year|bionomics.com.au - Net earnings per share change forecast for next year|Earnings growth forecast for next year NERV|ATHA (Athira) - Expected earnings per share trend next year|Addex Therapeutics - Expected earnings per share growth for next year|ALZN - Expected earnings per share growth for next year|Cyclerion Therapeutics, Inc. - Earnings growth forecast for next year|Expected earnings per share trend next year PTIX (Protagenic Therapeutics, Inc.)|KTTA (pasitheaclinics.com) - Expected earnings per share growth for next year|Projected earnings per share growth rate for next year CRGT|Expected earnings per share growth for next year ATXI|Expected earnings per share growth for next year Brainstorm Cell (BCLI)|Expected earnings per share growth for next year CARA (Cara Therapeutics, Inc.)|Expected earnings per share growth for next year Chromocell Therapeutics Corp CHRO|Earnings growth forecast for next year ELYM (Eliem Therapeutics, Inc.)|Earnings growth forecast for next year intracellulartherapies.com ITCI|Longboard Pharmaceuticals - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Marinus Pharmaceuticals, Inc. MRNS|NKGN: Earnings growth forecast for next year|NeuroBo Pharmaceuticals Inc - Expected earnings per share trend next year|SAGE (Sage Therapeutics Inc.) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year SNPX (Neurotrope)|Net earnings per share growth forecast for next year Trevena Inc. (TRVN)|VIGL - Expected net earnings per share growth next year|Anew Medical Inc. - Expected earnings per share growth for next year|CERE (Cerevel Therapeutics, Inc.) - Net earnings per share change forecast for next year